Apatinib in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: A Phase II, Open-Label, Single-Arm, Prospective Study.
Xinran MaLing LiLei ZhangXiaorui FuXin LiXinhua WangJingjing WuZhenchang SunXudong ZhangXiaoyan FengYu ChangZhiyuan ZhouFeifei NanJieming ZhangZhaoming LiMingzhi ZhangPublished in: Drug design, development and therapy (2020)
Home administration of apatinib shows promising efficacy and manageable AEs in patients with RR DLBCL.